What are the most important unanswered research questions in trial retention? A James Lind Alliance Priority Setting Partnership: the PRioRiTy II (Prioritising Retention in Randomised Trials) study
Dan Brunsdon(University of Aberdeen), Katie Gillies(University of Aberdeen), Jim Elliott(National Health Service), Sandra Galvin(Ollscoil na Gaillimhe – University of Galway), Imogen Skene(Barts Health NHS Trust), Caroline Whiting(University of Southampton), Andrew Worrall, Linda Biesty(Ollscoil na Gaillimhe – University of Galway), Joan Jordan(The Patients Association), Valerie Brueton(King's College London), Peter Brocklehurst(Cancer Research UK Clinical Trials Unit), Patricia Healy(Ollscoil na Gaillimhe – University of Galway), Irene Soulsby(University of Southampton), Declan Devane(Ollscoil na Gaillimhe – University of Galway), Derek Stewart, Shaun Treweek(University of Dundee), Doris Lanz(Queen Mary University of London), Beccy Maeso(University of Southampton), Sharon Wren(Royal National Institute for Deaf People), David Torgerson(University of York), Amanda Roberts(University of Aberdeen), Carrol Gamble(University of Liverpool), Heidi Gardner(University of Aberdeen), Kerenza Hood(NHS Digital)
Cited by 116
Related Papers
Midwife-led continuity models versus other models of care for childbearing women
|Cochrane Database of Systematic Reviews|2013|1.2k
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
|Osteoporosis International|2007|1.2k
Midwife-led continuity models versus other models of care for childbearing women
|Cochrane Database of Systematic Reviews|2016|924